Aim: In the followup of patients with advanced stage thyroid cancer radioio
dine scintigraphy, F-18-FDG PET and tumormarker hTg using stimulation with
recombinant human TSH (rhTSH) were compared to the results of some diagnost
ic procedures during TSH-suppression or endogenous TSH-stimulation. Methods
: 30 patients were investigated in hypothyroidism and after application of
rhTSH regarding the serum hormone concentrations, hTg, radioiodine scans an
d FGD-PET scans. Results: Radioiodine avidity and FDG uptake were significa
ntly higher in 7/30 and 3/5 patients, respectively, compared to endogenous
stimulation or TSH-suppression. In about one third of patients hTg increase
d more than 30%. Conclusion: Our preliminary results indicate a sufficient
feasibility and sensitivity of rhTSH not only in the follow-up by hTg and r
adioiodine scan but also in FDG-PET.